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Purpose :
Risuteganib is a novel synthetic peptide that has advanced
through Phase II clinical trials, showing promising efcacy in retinal
diseases, including dry age-related macular degeneration (AMD) and
diabetic macular edema (DME). This study is to explore the mechanism
of action (MOA) of risuteganib by uncovering its functional target(s)
and the associated cell layer.
Methods :
Fluorescent staining of mouse and rat retinal cryo-sections
was performed with risuteganib-dye conjugates and compared with
control peptide. Protective efects against oxidative stress was studied
in ARPE-19 cell line challenged with tert-Butyl Hydroperoxide (tBHP)
using WST-1 assay and Caspase 3/7 apoptosis assay. Mitochondrial
bioenergetics were measured using Seahorse XF cell mito stress test.
Results :
Peptide-dye staining of animal retinal tissue indicated
preferential localization of risuteganib in the RPE layer. 24hr
risuteganib pretreatment signifcantly rescued ARPE-19 cells from
tBHP-induced oxidative stress in WST-1 assay (p<0.05) and Caspase
3/7 apoptosis assay (p<0.01). Seahorse bioenergetics measurement of
ARPE-19 cells showed that risuteganib dose-dependently enhanced
mitochondrial basal, maximal and ATP-related respirations of RPE
cells.
Conclusions :
Oxidative stress is one of the hallmarks of retinal diseases
AMD and DME, and is associated with impaired RPE function. The
observations of preferential binding to RPE layers in retina and the
protection of mitochondrial function in RPE cells against oxidative
stress in vitro, suggest that the clinically observed therapeutic efect of
risuteganib in dry AMD and DME may be associated with supporting
RPE cells and maintaining mitochondrial stability and function. Such a
novel MOA of risuteganib could lead to new strategies for treatment of
retinal diseases.
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